Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05880810 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

A NA study of Diabetes Mellitus, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05880810 is a NA study of Diabetes Mellitus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05880810, a NA study of Diabetes Mellitus, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).

Conditions Studied

Interventions

  • DEVICE Continuous Glucose Monitor Dexcom G6 PRO

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-05-01
Est. Completion 2027-05
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05880810

The ClinicalTrials.gov registry entry for NCT05880810 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor Dexcom G6 PRO is the first listed.

NCT05880810 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05880810 about?

NCT05880810 is a clinical study titled "Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients". The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy wi...

What is the current status of trial NCT05880810?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-01. Estimated completion is 2027-05.

What conditions does trial NCT05880810 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT05880810?

The interventions under investigation include: Continuous Glucose Monitor Dexcom G6 PRO (DEVICE).

Who is sponsoring clinical trial NCT05880810?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05880810 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.